Perspective Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -43,959 | -14,384 | -10,680 | -11,438 |
EBIT | -44,680 | -15,053 | -11,250 | -11,784 |
Net Income | -40,169 | -15,122 | -11,704 | -12,284 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -41,220 | -26,347 | -9,917 | 4,776 |
Cash | 61,580 | 226,443 | 252,004 | 142,117 |
Basic Shares | 67,587 | 70,629 | 66,648 | 49,510 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,434 | $7,104 | $7,104 |
Gross Profit | 1,434 | 1,634 | 1,634 | |
EBITDA | 10,459 | -39,960 | -14,838 | -14,838 |
EBIT | -40,941 | -15,182 | -15,182 | |
Net Income | -79,279 | -46,508 | -14,670 | -14,670 |
Net Change In Cash | 0 | 1,434 | 7,104 | 7,104 |
Free Cash Flow | -72,708 | -37,985 | -12,474 | -12,474 |
Cash | 61,580 | 9,238 | 20,993 | 20,993 |
Basic Shares | 644 | 26,764 | 142,103 | 142,103 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.24 |
2024-09-30 | -$0.21 |
2024-06-30 | -$0.18 |
2024-03-31 | -$0.20 |
